Utilization of arsenic trioxide as a treatment of cisplatin-resistant non-small cell lung cancer PC-9/CDDP and PC-14/CDDP cells

Author：          

Publisher： Spandidos Publications

E-ISSN： 1792-1082|10|2|805-809

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.2, 2015-01, pp. : 805-809

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Matrine induces mitochondrial apoptosis in cisplatinresistant non-small cell lung cancer cells via suppression of β-catenin/survivin signaling

By      

Oncology Reports, Vol. 33, Iss. 5, 2015-01 ,pp. : 2561-2566

Spandidos Publications

Access to resources Recommend Favorite

Effects of Collagen IV on Cisplatin-Induced Apoptosis of Non-Small Cell Lung Cancer Cells

By Su Chunxia   Su Bo   Tang Liang   Zhao Yinmin   Zhou Caicun  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 542-549

Informa Healthcare

Access to resources Recommend Favorite

PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells

By Cheng Haiying  

Carcinogenesis, Vol. 34, Iss. 4, 2013-04 ,pp. : 739-749

Oxford University Press

Access to resources Recommend Favorite

REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells

By                

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1460-1468

Spandidos Publications

Access to resources Recommend Favorite

Two consecutive days of treatment with liposomal cisplatin in non-small cell lung cancer

By      

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1013-1016

Spandidos Publications

Access to resources Recommend Favorite